Answers are grounded in this paper and cite their sources.
Nogo-B has been implicated in many metabolic diseases including diabetes mellitus. It is still unclear whether the levels of serum Nogo-B decrease in patients with diabetic foot infection (DF). We retrospectively collected sera of T2DM patients with or without DF from the First Affiliated Hospital of Chongqing Medical University. Human Nogo-B ELISA Kit (Jiubang Biotechnology Cat number: QZ-17338) was used to determine serum Nogo-B levels in all the samples. Graphpad and SPSS version 27 software were used for statistical analyses. T2DM patients with DF displayed lower levels of Nogo-B than those without DF (18.66 ± 4.16 ng/ml versus 26.77 ± 3.27 ng/ml, respectively; P < 0.001). In addition, lower levels of Nogo-B were associated with DF [OR (95% CI) = 0.528 (0.436–0.640), P < 0.001]. This association was independent of other factors associated with DF [OR (95% CI) = 0.413 (0.244–0.702), P = 0.001). The results of our study highlight the association of lower levels of Nogo-B with DF. Our findings describe associations and cannot establish causation. Future studies should be conducted to verify or confirm our findings.
No takes yet. Share an insight, caveat, or question.
IRAKOZE et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: